Prostate cancer is the most commonly diagnosed malignancy in United States males. Unfortunately, numerous controversies surround clinical management for early stage disease and the utility of population screening. Much of this controversy stems from the lack of knowledge about the biology of prostate cancer, including the lack of clearly defined risk factors, absence of markers indicative of aggressive clinical behavior, as well as a lack of a clear understanding of its underlying genetic features. This paper reviews currently available evidence regarding the genetic characteristics of adenocarcinoma of the prostate, including the impact of family history on disease risk, the nature of structural genetic aberrations, and the possible role o...
Tremendous advances in genomic capabilities, including high-throughput genotyping technology and alg...
Prostate cancer is the most frequent cancer among men in most developed countries, yet little is kno...
Prostate cancer is the most common cancer in men in Europe and the United States. The genetic herita...
Prostate cancer is the most commonly diagnosed noncutaneous tumor in North American men and confers ...
Item does not contain fulltextA genetic component in prostate cancer has been recognized since decad...
Among United States men, prostate cancer is the most commonly diagnosed cancer, and the second most ...
Prostate cancer afflicts one man in nine over the age of 65 and represents the most frequently diagn...
A genetic component in prostate cancer has been recognized for decades. Through numerous epidemiolog...
Prostate cancer (PCa) is a challenging polygenic disease because the genes that cause PCa remain lar...
Prostate cancer (PC) is a significant economic and health burden in the U.S. and Europe but its caus...
Prostate cancer (PCa) remains the most common cancer in men. The proportion of all PCa attributable ...
Prostate cancer (PCa) remains the most common cancer in men. The proportion of all PCa attributable ...
This thesis is based on research concerning epidemiological, clinical, and psychological aspects of ...
Item does not contain fulltextCONTEXT: Despite widespread screening for prostate cancer (PCa) and ma...
CONTEXT: Despite widespread screening for prostate cancer (PCa) and major advances in the treatment ...
Tremendous advances in genomic capabilities, including high-throughput genotyping technology and alg...
Prostate cancer is the most frequent cancer among men in most developed countries, yet little is kno...
Prostate cancer is the most common cancer in men in Europe and the United States. The genetic herita...
Prostate cancer is the most commonly diagnosed noncutaneous tumor in North American men and confers ...
Item does not contain fulltextA genetic component in prostate cancer has been recognized since decad...
Among United States men, prostate cancer is the most commonly diagnosed cancer, and the second most ...
Prostate cancer afflicts one man in nine over the age of 65 and represents the most frequently diagn...
A genetic component in prostate cancer has been recognized for decades. Through numerous epidemiolog...
Prostate cancer (PCa) is a challenging polygenic disease because the genes that cause PCa remain lar...
Prostate cancer (PC) is a significant economic and health burden in the U.S. and Europe but its caus...
Prostate cancer (PCa) remains the most common cancer in men. The proportion of all PCa attributable ...
Prostate cancer (PCa) remains the most common cancer in men. The proportion of all PCa attributable ...
This thesis is based on research concerning epidemiological, clinical, and psychological aspects of ...
Item does not contain fulltextCONTEXT: Despite widespread screening for prostate cancer (PCa) and ma...
CONTEXT: Despite widespread screening for prostate cancer (PCa) and major advances in the treatment ...
Tremendous advances in genomic capabilities, including high-throughput genotyping technology and alg...
Prostate cancer is the most frequent cancer among men in most developed countries, yet little is kno...
Prostate cancer is the most common cancer in men in Europe and the United States. The genetic herita...